DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials.
Saved in:
| Title: | DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials. |
|---|---|
| Authors: | Morgan, C.1, Jin, X.2, Yu, X.1, De Rosa, S.1, Kublin, J.1, Metch, B.1, Keefer, M.2, Niaid, H.1 |
| Source: | Retrovirology. 2012 Supplement, Vol. 9 Issue Suppl 2, p1-1. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
